Cargando…
The economic burden of prostate cancer – a Swedish prevalence-based register study
BACKGROUND: Incidence and prevalence of prostate cancer in Sweden have increased markedly due to prostate-specific antigen (PSA) testing. Moreover, new diagnostic tests and treatment technologies are expected to further increase the overall costs. Our aims were (i) to estimate the societal costs for...
Autores principales: | Hao, Shuang, Östensson, Ellinor, Eklund, Martin, Grönberg, Henrik, Nordström, Tobias, Heintz, Emelie, Clements, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238534/ https://www.ncbi.nlm.nih.gov/pubmed/32434566 http://dx.doi.org/10.1186/s12913-020-05265-8 |
Ejemplares similares
-
Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study
por: Hao, Shuang, et al.
Publicado: (2022) -
The economic burden of prostate cancer in Eswatini
por: Ngcamphalala, Cebisile, et al.
Publicado: (2022) -
The economic burden of cervical cancer in Eswatini: Societal perspective
por: Ngcamphalala, Cebisile, et al.
Publicado: (2021) -
The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019) -
The cost-effectiveness of prostate cancer screening using the Stockholm3 test
por: Karlsson, Andreas A., et al.
Publicado: (2021)